Mental health · Clermont, FL
Mental health studies in Clermont, FL
5 recruiting studies have a site in Clermont.
5 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- Clermont, FL + 56 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 2
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
Alkermes, Inc.
- Location
- Clermont, FL + 17 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
ACADIA Pharmaceuticals Inc.
- Location
- Clermont, FL + 27 other US sites
- Eligibility basics
- Ages 55–84
- RecruitingPhase 3
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- Clermont, FL + 7 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 2
Study of ALTO-300 in MDD
Alto Neuroscience
- Location
- Clermont, FL + 36 other US sites
- Eligibility basics
- Ages 18–70
Who these studies look for
Studies usually require a confirmed diagnosis and stable circumstances, and they monitor safety closely. If you are in crisis, contact a crisis line or emergency services rather than a study.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.